Mark R. Vesely

2.0k total citations
34 papers, 826 citations indexed

About

Mark R. Vesely is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Mark R. Vesely has authored 34 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Mark R. Vesely's work include Coronary Interventions and Diagnostics (10 papers), Cardiac and Coronary Surgery Techniques (9 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Mark R. Vesely is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Cardiac and Coronary Surgery Techniques (9 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Mark R. Vesely collaborates with scholars based in United States, Austria and China. Mark R. Vesely's co-authors include Priya Duggal, Alan H. Beggs, Duangrurdee Wattanasirichaigoon, Juan Villafañe, Carol Satler, Vasken Dilsizian, Johannes Bonatti, David Zimrin, Eric J. Lehr and Geoffrey S. Ginsburg and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Mark R. Vesely

33 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark R. Vesely United States 16 659 361 221 79 76 34 826
Eckhard Schwertfeger Germany 13 213 0.3× 152 0.4× 114 0.5× 66 0.8× 129 1.7× 19 548
Neri M. Cohen United States 17 554 0.8× 606 1.7× 75 0.3× 253 3.2× 47 0.6× 29 1.0k
M C Chin United States 12 791 1.2× 147 0.4× 123 0.6× 78 1.0× 21 0.3× 16 1.1k
C. Mussap Australia 14 260 0.4× 242 0.7× 172 0.8× 283 3.6× 64 0.8× 52 649
Ans C.P. Wiesfeld Netherlands 24 2.2k 3.4× 701 1.9× 103 0.5× 103 1.3× 27 0.4× 67 2.5k
Paschalis‐Adam Molyvdas Greece 14 202 0.3× 195 0.5× 55 0.2× 65 0.8× 121 1.6× 42 618
Walter Kao United States 11 197 0.3× 172 0.5× 111 0.5× 116 1.5× 20 0.3× 24 499
Tino Münster Germany 11 125 0.2× 81 0.2× 148 0.7× 36 0.5× 39 0.5× 33 601
Gerry Van der Mieren Belgium 11 289 0.4× 217 0.6× 115 0.5× 39 0.5× 130 1.7× 24 553
Xia Sheng China 13 506 0.8× 124 0.3× 96 0.4× 57 0.7× 55 0.7× 39 752

Countries citing papers authored by Mark R. Vesely

Since Specialization
Citations

This map shows the geographic impact of Mark R. Vesely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Vesely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Vesely more than expected).

Fields of papers citing papers by Mark R. Vesely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Vesely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Vesely. The network helps show where Mark R. Vesely may publish in the future.

Co-authorship network of co-authors of Mark R. Vesely

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Vesely. A scholar is included among the top collaborators of Mark R. Vesely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Vesely. Mark R. Vesely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Xin, et al.. (2024). Recurrent Stent Thrombosis Following Myocardial Infarction Associated With VITT-Like Antibodies. JACC Case Reports. 29(5). 102234–102234. 1 indexed citations
2.
Pasrija, Chetan, Rachael W. Quinn, Douglas Tran, et al.. (2020). Development of a Reproducible Swine Model of Chronic Ischemic Mitral Regurgitation: Lessons Learned. The Annals of Thoracic Surgery. 111(1). 117–125. 3 indexed citations
3.
Quan, Wei, Aakash Shah, Erika Feller, et al.. (2018). Transcatheter closure of atrial septostomy facilitates minimally invasive left ventricular assist device implantation. Journal of Thoracic and Cardiovascular Surgery. 158(1). e7–e9. 2 indexed citations
4.
Wehman, Brody, Mark R. Vesely, Tieluo Li, et al.. (2016). Intracoronary Stem Cell Delivery to the Right Ventricle: A Preclinical Study. Seminars in Thoracic and Cardiovascular Surgery. 28(4). 817–824. 4 indexed citations
5.
Bonaros, Nikolaos, Thomas Schachner, Markus Kofler, et al.. (2014). Advanced hybrid closed chest revascularization: an innovative strategy for the treatment of multivessel coronary artery disease†. European Journal of Cardio-Thoracic Surgery. 46(6). e94–e102. 19 indexed citations
6.
Weidinger, F, Thomas Schachner, Nikolaos Bonaros, et al.. (2013). Predictors and consequences of postoperative atrial fibrillation following robotic totally endoscopic coronary bypass surgery. European Journal of Cardio-Thoracic Surgery. 45(2). 318–322. 24 indexed citations
7.
Bonatti, Johannes, David Zimrin, Eric J. Lehr, et al.. (2012). Hybrid Coronary Revascularization Using Robotic Totally Endoscopic Surgery: Perioperative Outcomes and 5-Year Results. The Annals of Thoracic Surgery. 94(6). 1920–1926. 51 indexed citations
8.
Vesely, Mark R., et al.. (2012). Advanced hybrid coronary revascularization with robotic totally endoscopic triple bypass surgery and left main percutaneous intervention. Journal of Thoracic and Cardiovascular Surgery. 144(4). 986–987. 3 indexed citations
9.
Vesely, Mark R., et al.. (2012). Acute Coronary Syndromes. Cardiology Clinics. 30(4). 617–627. 2 indexed citations
10.
Vesely, Mark R. & Vasken Dilsizian. (2011). Microvascular Angina: Assessment of Coronary Blood Flow, Flow Reserve, and Metabolism. Current Cardiology Reports. 13(2). 151–158. 7 indexed citations
11.
Vesely, Mark R., et al.. (2011). Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions. Clinical Pharmacology & Therapeutics. 89(3). 455–459. 25 indexed citations
12.
Lehr, Eric J., David Zimrin, Mark R. Vesely, et al.. (2010). Axillary-Coronary Sequential Vein Graft for Total Endoscopic Triple Coronary Artery Bypass. The Annals of Thoracic Surgery. 90(5). e79–e81. 10 indexed citations
13.
Zimrin, David, Johannes Bonatti, Mark R. Vesely, & Eric J. Lehr. (2010). Hybrid Coronary Revascularization: An Overview of Options for Anticoagulation and Platelet Inhibition. The Heart Surgery Forum. 13(6). E405–E408. 1 indexed citations
14.
Bonatti, Johannes, Eric J. Lehr, Mark R. Vesely, et al.. (2010). Hybrid coronary revascularization: which patients? when? how?. Current Opinion in Cardiology. 25(6). 568–574. 29 indexed citations
15.
Vesely, Mark R. & Vasken Dilsizian. (2008). Nuclear Cardiac Stress Testing in the Era of Molecular Medicine. Journal of Nuclear Medicine. 49(3). 399–413. 38 indexed citations
17.
Gottlieb, Stephen S., Willem J. Kop, Sue Thomas, et al.. (2007). A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. American Heart Journal. 153(5). 868–873. 91 indexed citations
18.
Satler, Carol, Mark R. Vesely, Priya Duggal, Geoffrey S. Ginsburg, & Alan H. Beggs. (1998). Multiple different missense mutations in the pore region of HERG in patients with long QT syndrome. Human Genetics. 102(3). 265–272. 50 indexed citations
19.
Prigodich, Richard V. & Mark R. Vesely. (1997). Characterization of the Complex between Bovine Osteocalcin and Type I Collagen. Archives of Biochemistry and Biophysics. 345(2). 339–341. 27 indexed citations
20.
Satler, Carol, et al.. (1996). Novel missense mutation in the cyclic nucleotide‐binding domain of HERG causes long QT syndrome. American Journal of Medical Genetics. 65(1). 27–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026